Award-winning sepsis project gets $13M and a shot at reopening an R&D avenue as FDA pitches out old gold standard

Award-winning sepsis project gets $13M and a shot at reopening an R&D avenue as FDA pitches out old gold standard – ENDPOINTS NEWS:



As chair of the British Heart Foundation’s translational awards committee, David Grainger was powerfully attracted to some research that Glasgow University professor James Leiper was doing on a common symptom of septic shock, a major killer that is responsible for more than a quarter million deaths in the US each year.

As chair of the British Heart Foundation’s translational awards committee, David Grainger was powerfully attracted to some research that Glasgow University professor James Leiper was doing on a common symptom of septic shock, a major killer that is responsible for more than a quarter million deaths in the US each year.

As chair of the British Heart Foundation’s translational awards committee, David Grainger was powerfully attracted to some research that Glasgow University professor James Leiper was doing on a common symptom of septic shock, a major killer that is responsible for more than a quarter million deaths in the US each year.

As chair of the British Heart Foundation’s translational awards committee, David Grainger was powerfully attracted to some research that Glasgow University professor James Leiper was doing on a common symptom of septic shock, a major killer that is responsible for more than a quarter million deaths in the US each year.